Bharat Biotech International Ltd (BBIL) on Monday said it has completed the phase-III and booster dose trials for its intranasal Covid-19 vaccine BBV154, and it has proven to be safe. Photograph:......
Founders of indigenous COVID-19 vaccine developer Bharat Biotech -- Krishna Ella and Suchitra Ella, along with Cyrus Poonawalla, the chairman and MD of another vaccine manufacturer Serum Institute......
Bharat Biotech has completed the Phase 2/3 trials of COVID-19 vaccine, Covaxin for use in children under 18 years of age and is expected to submit the data by next week to the Drugs Controller......
Brazil has suspended the clinical studies of Bharat Biotech's COVID-19 vaccine, Covaxin following termination of the company's agreement with its partner there, the South American Country's......
India's Covaxin, developed by Bharat Biotech in collaboration with the Indian Council of Medical Research, effectively neutralises both Alpha and Delta variants of coronavirus, the United States'......
Unlike many of his peers in corporate houses, Kumar doesn't have an MBA but says that hardly matters, as he has been lucky to have got great on-the-job experience, such as during his stint in Asia......
Madhurawada, located along the north-east of Vizag or Visakhapatnam, along National Highway-5, is an upcoming residential area, thanks to the major developments driven by the Information Technology......
This is the amazing story of Dr Krishna M Ella, a scientist who turned into a serial entrepreneur. Krishna Ella, chairman and managing director of Bharat Biotech International Ltd, is one of the......
When the Andhra Pradesh government identified biotechnology as one of the engines of economic growth for the state, it came as a surprise for many. After all, Shantha Biotech and Bharat Biotech......
Foreign institutional investors are not active in the secondary market alone -- they have been buying substantial chunks of shares in Indian companies by using global depository receipts,......